CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities:
Net loss	$ (2,662,741)	$ (3,234,320)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	75,067	135,052
Stock based compensation expense	205,490	490,244
Amortization of debt issuance costs	6,157	4,492
Provision for bad debts	0	(8,633)
Change in operating assets and liabilities:
Accounts receivable	565,982	879,807
Inventories	59,946	(3,920)
Prepaid expenses, other current assets and deposits	(13,337)	6,314
Accounts payable and accrued liabilities	(793,895)	198,713
Deferred revenue	(173,942)	18,583
Net cash used in operating activities	(2,731,273)	(1,513,668)
Cash flows from investing activities:
Purchase of property and equipment	0	(52,051)
Net cash used in investing activities	0	(52,051)
Cash flows from financing activities:
Net proceeds from secured convertible promissory notes, related parties	0	550,000
Repayment of secured convertible promissory notes	(107,802)	0
Net proceeds from sale of common stock and warrants	10,942,940	2,493,999
Net cash provided by financing activities	10,835,138	3,043,999
Net increase in cash and cash equivalents	8,103,865	1,478,280
Cash and cash equivalents at beginning of period	558,988	1,659,564
Cash and cash equivalents at end of period	8,662,853	3,137,844
Supplemental Disclosures of Cash Flow Information:
Cash paid during year for interest	0	0
Cash paid during year for income taxes	0	0
Non-cash investing and financing activities:
Interest paid in kind	35,625	0
Deemed dividend-warrant repricing	2,842	0
Impact of adoption of new accounting pronouncements included in accumulated deficit	0	493,223
Deferred offering costs reclassified to additional paid in capital	109,698	0
Public offering costs incurred, and included in accounts payable	$ 303,212	$ 231,520